ACORDA THERAPEUTICS INC 4

4 · ACORDA THERAPEUTICS INC · Filed Jun 10, 2016

Form 4

Period: 2016-06-08

Director

Transactions

Exercise/Conversion
Common Stock
2016-06-08$18.65/sh+1,086$20,254→ 1,086 total
Exercise/Conversion
Non-Employee Stock Option
2016-06-08−1,086→ 0 total
Exercise: $18.65Exp: 2016-12-01→ Common Stock (1,086 underlying)
Sale
Common Stock
2016-06-08$27.83/sh−1,086$30,224→ 0 total
Award
Non-Employee Stock Option
2016-06-08+15,000→ 15,000 total
Exercise: $27.93Exp: 2026-06-08→ Common Stock (15,000 underlying)

Footnotes (4)

[F1]Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
[F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $27.58 to $28.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]The shares subject to these options vested in installments and were fully vested on December 1, 2007.
[F4]The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 8, 2016, with the first quarterly installment on vesting September 8, 2016.

Documents

1 file